Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: FDA approves preventive treatment for influenza

( - Switzerland's Roche said on Tuesday that the US Food and Drug Administration (FDA) has approved its supplemental new drug application for Xofluza as a treatment to prevent influenza following contact with an infected person.

In a phase III study, the proportion of household members 12 years of age and older who developed influenza was 1% in participants treated with Xofluza - a drug that is already FDA-approved to treat acute uncomplicated influenza - compared to 13% in the placebo-treated group, the drugmaker said.

The move comes as the US is about to enter the flu season - which millions of people suffer from every year - in the midst of the global COVID-19 pandemic.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.